Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-015340
Filing Date
2022-04-25
Accepted
2022-04-25 07:30:14
Documents
4
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A_PROXY 2022 itrm-def14a_20220615.htm DEF 14A 1882446
2 GRAPHIC gj0ie2s2nd15000002.jpg GRAPHIC 90778
3 GRAPHIC gj0ie2s2nd15000003.jpg GRAPHIC 83899
4 GRAPHIC gj0ie2s2nd15000001.jpg GRAPHIC 6249
  Complete submission text file 0001564590-22-015340.txt   2133212
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38503 | Film No.: 22847324
SIC: 2834 Pharmaceutical Preparations